Relmada Therapeutics (RLMD) files mixed shelf
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 falls from record high as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Form S-3ASR RELMADA THERAPEUTICS,
May 13, 2026 4:53 PM EDTAs filed with the Securities and Exchange Commission on May 13, 2026
Registration No. 333-
... More